NCT01288378 - Empirical Versus Preemptive Antifungal Therapy | Biotech Hunter

Enrollment

556

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 4, 2019

Study Completion Date

April 4, 2019

Conditions

Fungal InfectionLeukemiaMyelodysplastic Syndromes

Interventions

DRUG

caspofungin acetate

intravenous route, at a 70 mg loading dose on day 1 of antifungal therapy, followed by 50 mg once a day thereafter.

Trial Locations (16)

A.Z. St. Jan, Bruges

Cliniques Universitaires Saint-Luc, Brussels

Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet, Brussels

U.Z. Gasthuisberg, Leuven

C.H.U. Sart-Tilman, Liège

Masaryk University, Brno

CHU de Caen - Hopital Cote de Nacre, Caen

C.H.U. Henri Mondor AP-HP, Créteil

CHRU de Lille - Hopital Hurie, Lille

CHU de Limoges - Hopital Dupuytren, Limoges

Hopital Universitaire Hautepierre, Strasbourg

Institut Gustave Roussy, Villejuif

Universitaetsklinikum Freiburg, Freiburg im Breisgau

Universitaetsklinikum Wuerzburg - Medizinische Klinik und Poliklinik II, Würzburg

Radboud University Nijmegen Medical Centre, Nijmegen

National Cancer Institute, Bratislava

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK